Radiesse (+) Lidocaine injectable implant is indicated for plastic/reconstructive procedures, including deep dermal and subdermal soft tissue augmentation of the facial area and is also intended for restoration and correction of facial volume loss (lipoatrophy) in the facial area and for rejuvenation of the hands. Radiesse (+) Lidocaine should not be used on patients: with known hypersensitivity to any of
the components or amide anesthetics; prone to inflammatory skin conditions, hypertrophic scars/ keloids or poor wound healing; with bleeding disorders or inflamed/ infected skin; in the presence of foreign bodies/implants; in the epidermis, glabellar or lip mucosa; taking anti-coagulants; in pregnancy or lactation; others. This medical device must be administered by a Healthcare Professional. If you
are a Healthcare Professional, please review the Radiesse (+) Lidocaine Instruction for Use before prescribing, available from www.merzaustralia.com. au/our-competencies/aesthetics/products/.
To report an adverse event or for urgent medical information please email safetyANZ@merz.com or medinfoaustralia@merz.com respectively, or call (02) 8076 8139 for Australia and 0800 822310 for
New Zealand.
For information about how Merz handles personal data, please see Merz General Data Protection. Information Notice at http://www.merz.com/fin. Copyright ©2021. Merz Australia Pty Ltd. All rights reserved. Radiesse (+) and Merz Aesthetics are registered trademarks of Merz Pharma GMbh &Co.KGaA. ANZ_RAD+_AMP_SUMMER:NOV:21. Date of preparation November 2021. TAPS MR7889